Id: | acc4779 |
Group: | 1sens |
Protein: | Akt |
Gene Symbol: | Akt1 |
Protein Id: | P47196 |
Protein Name: | AKT1_RAT |
PTM: | phosphorylation |
Site: | Ser473 |
Site Sequence: | ERRPHFPQFSYSASGTA---- |
Disease Category: | Nervous system diseases |
Disease: | Cognitive Abnormalities |
Disease Subtype: | Cognitive Dysfunction |
Disease Cellline: | |
Disease Info: | |
Drug: | IGF-1 |
Drug Info: | "IGF - 1, also known as Insulin - like Growth Factor 1, plays a significant role in cell growth and development." |
Effect: | modulate |
Effect Info: | Intravenous injection of IGF-1 rescued sevoflurane-induced suppression of Akt phosphorylation in aged rats and alleviated cognitive impairment. |
Note: | |
Score: | 4.0 |
Pubmed(PMID): | 33949883 |
Sentence Index: | 33949883_8 |
Sentence: | "In aged rats, intravenous injection of IGF-1 alleviated sevoflurane-caused cognitive injuries and elevated TNF-alpha, IL-1beta, and IL-6 levels in the plasma and hippocampus and rescued sevoflurane-depressed Akt phosphorylation." |
Sequence & Structure:
MNDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVEQRESPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKRQEEETMDFRSGSPSDNSGAEEMEVALAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPTQRLGGGSEDAKEIMQHRFFANIVWQDVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFSYSASGTA
No data.
No data.
Protein Tractability:
source: Open TargetsNo data.
PTM Intensity:
source: CPTACNo data.
PTM-Disease Association:
source: PTMDResidue | Position | State | Disease | Class | PMID |
---|---|---|---|---|---|
S | 473 | D | Major depressive disorder | Phosphorylation | 16959794 |
S | 473 | D | Type 2 diabetes | Phosphorylation | 34057658 ;  36374861 |
S | 473 | U | Status epilepticus | Phosphorylation | 35562960 |
State Note: Based on the distinct PTM states in diseases, PTMD classified all disease-associated PTMs into six classes, including whether the up-regulation (U) or down-regulation (D) of PTM levels, the absence (A) or presence (P) of PTMs, and the creation (C) or disruption (N) of PTM sites are associated with diseases.
PTM-Drug Perturbation Response:
source: DecryptMNo data.
Function score:
source: funscoRNo data.